Home 4th National Point of Care Testing Symposium
Article
Licensed
Unlicensed Requires Authentication

4th National Point of Care Testing Symposium

Published/Copyright: April 12, 2022

Received: 2022-03-26
Accepted: 2022-03-28
Published Online: 2022-04-12
Published in Print: 2022-05-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Statistics in diagnostic medicine
  4. Interferences in immunoassays: review and practical algorithm
  5. EFLM Paper
  6. The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
  7. General Clinical Chemistry and Laboratory Medicine
  8. Benchmarking medical laboratory performance: survey validation and results for Europe, Middle East, and Africa
  9. Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1
  10. Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making
  11. Implementation and challenges of portable blood gas measurements in air medical transport
  12. Calculation of the estimated glomerular filtration rate using the 2021 CKD-EPI creatinine equation and whole blood creatinine values measured with Radiometer ABL 827 FLEX
  13. Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall?
  14. Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin
  15. Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition
  16. Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
  17. Reference Values and Biological Variations
  18. Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort
  19. Cardiovascular Diseases
  20. High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
  21. Infectious Diseases
  22. Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
  23. The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers
  24. Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry
  25. Prognostic significance of soluble CD25 in patients with sepsis: a prospective observational study
  26. Letters to the Editors
  27. Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
  28. Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold
  29. CSF-interleukin 6 for early diagnosis of ventriculitis in a broad intensive care setting
  30. Clearance of macro-TSH from the circulation is slower than TSH
  31. Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?
  32. Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
  33. Diagnostic performance characteristics of the Quanta Flash Rheumatoid Factor assay in a consecutive Dutch patient cohort
  34. Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy
  35. Congress Abstracts
  36. 4th National Point of Care Testing Symposium
Downloaded on 3.7.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0295/html
Scroll to top button